Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 21.44±12.82 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 35.48 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 33.05±4.21 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 5-Nitroanthracene | 602-60-8 | 602N608 |
| 8981AB | 9-NITROANTHRACENE | 9-Nitro anthracene |
| 9-Nitro-anthracene | 9-Nitroanthracene, 93% | 9-Nitroanthracene, BCR(R) certified Reference Material |
| 9-Nitroanthracene, matrix substance for MALDI-MS, >=98.5% (HPLC) | A832660 | ACMC-20ab5c |
| AK102814 | AKOS003595740 | ANW-65374 |
| AS-56867 | AX8234353 | Anthracene, 9-nitro- |
| C19470 | CAS-602-60-8 | CCRIS 4679 |
| CHEBI:82501 | CHEMBL166112 | CTK2F8141 |
| DB-022278 | DSSTox_CID_5730 | DSSTox_GSID_25730 |
| DSSTox_RID_77896 | DTXSID5025730 | EINECS 210-021-9 |
| FT-0621681 | HMS3039K17 | InChI=1/C14H9NO2/c16-15(17)14-12-7-3-1-5-10(12)9-11-6-2-4-8-13(11)14/h1-9H; |
| JZ1TB3N57P | LS-1435 | LSIKFJXEYJIZNB-UHFFFAOYSA- |
| LSIKFJXEYJIZNB-UHFFFAOYSA-N | MCULE-1577784817 | MLS002454383 |
| N0987 | NCGC00091602-01 | NCGC00091602-02 |
| NCGC00091602-03 | NSC 47175 | NSC-47175 |
| NSC47175 | PubChem15119 | Q27156005 |
| SBB069528 | SCHEMBL57759 | SMR001372000 |
| ST24024596 | ST45021344 | STK044217 |
| TR-020832 | Tox21_400025 | UNII-JZ1TB3N57P |
| W-203247 | ZINC157489 |